ZPL-3893787

DRUG2 trials

Sponsors

Ziarco Pharma Ltd

Conditions

Atopic DermatitisPsoriasis

Phase 2

A Study to Determine the Efficacy of ZPL-3893787 in Subjects With Atopic Dermatitis

CompletedNCT02424253

Ziarco Pharma LtdAtopic Dermatitis

Start: 2015-05-18End: 2016-02-03Updated: 2021-06-10

A Study to Determine the Efficacy of ZPL-3893787 in Subjects With Plaque Psoriasis

CompletedNCT02618616

Ziarco Pharma LtdPsoriasis

Start: 2016-01-11End: 2016-12-22Updated: 2021-07-20